A new Covid variant that’s gaining momentum globally has landed in the U.S. The World Health Organization announced last week that it was monitoring the variant, NB.1.8.1, following a rise in ...

A new COVID-19 variant that was unheard of just months ago is now projected to be the second-most common strain in the United States.. Variant NB.1.8.1 was first detected in China in January but ...

A painful sore throat, often referred to as "razor blade throat", is just one of the symptoms of a new COVID-19 variant. This variant is currently being monitored by the World Health Organization.

The COVID variant NB.1.8.1 may cause a distinctive "razor blade throat" symptom, though experts note that extreme pharyngitis can also be caused by bacterial infections and allergies.

Experts warn about risks of new COVID-19 vaccine guidelines 04:32. The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for ...

Still, that may not change the advice you get from your doctor. Should Pregnant People Get the COVID Shot? Kennedy's announcement did not explain why the recommendation for pregnant women changed.

An analysis of 435 studies from around the world in 2019-2020 found that pregnant and recently pregnant women who were infected with COVID were more likely to end up in intensive care units, be on ...

When the COVID-19 pandemic hit, there was a moment when some people thought it could be a unifying time for the U.S., like the way Americans came together in the aftermath of the Sept. 11, 2001 ...

This Alarming COVID Symptom Is Everywhere With The Latest Variant. We Asked Experts What You Need To Know. Jillian Wilson. Tue, June 10, 2025 at 8:33 PM UTC. 5 min read.

Government website on pandemic information now doubles down on lab-leak theory 05:11. The Trump administration has moved to take down COVID-19 signage from federal agencies and replace websites ...

Deaths. Since the pandemic began, more than 1.22 million Americans have died from COVID-19 as of March 6, 2025, according to the latest CDC data.The U.S. crossed the 1 million mark on May 12, 2022 ...

1st COVID drug hits the market. In May 2020, remdesivir became the first drug approved for emergency use by the FDA to treat patients with severe COVID cases.